If we could do that and we could reduce the significant amount that we are paying in rebates to intermediaries who are not passing those rebates on to lower out-of-pocket costs, speaking on behalf of Bristol-Myers Squibb, we could work almost immediately to begin to bring down list prices.
Kaine highlights potential for immediate price reductions through reform.
Share & report
More from Tim Kaine
Signal has not been approved for use by U.S. government officials for the sharing of classified information.
I fear deeply we're being misled about this, just as we were before we tragically got into a war with Iraq.
The Mexican government’s unfair targeting of Vulcan Materials Company, a U.S.-based company that employs over 1,000 people in Virginia, is harmful to the relationship between our two countries and severely undermines investor confidence.
Other voices in this conversation
